Autonomix Medical AMIX
Jump To Section
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of Autonomix Medical (AMIX)
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
Key Insights
Critical company metrics and information
Latest Closing Price
$2.65Market Cap
$6.53 MillionPrice-Earnings Ratio
0.82Total Outstanding Shares
2.46 Million SharesTotal Employees
8Dividend
No dividendIPO Date
January 29, 2024SIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
NASDAQType
Common StockHeadquarters
21 waterway avenue, suite 300, The woodlands, TX, 77380Homepage
https://www.autonomix.com
Historical Stock Splits
If you bought 20 shares of AMIX before October 25, 2024, you'd have 1 share today.
Execution Date | Split Amount |
---|---|
October 25, 2024 | 1-for-20 (Reverse Split) |
Cash Flow Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Net Cash Flow From Operating Activities, Continuing | $-8.04 Million |
Net Cash Flow From Operating Activities | $-8.04 Million |
Net Cash Flow From Investing Activities, Continuing | $-13,000 |
Net Cash Flow | $10.61 Million |
Net Cash Flow, Continuing | $10.61 Million |
Net Cash Flow From Financing Activities, Continuing | $18.65 Million |
Income Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Basic Average Shares | $15.06 Million |
Income/Loss From Continuing Operations Before Tax | $-13.63 Million |
Other Operating Expenses | $6.88 Million |
Basic Earnings Per Share | $3.25 |
Income/Loss From Continuing Operations After Tax | $-13.63 Million |
Net Income/Loss Available To Common Stockholders, Basic | $-13.63 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Other Comprehensive Income/Loss | $0 |
Comprehensive Income/Loss Attributable To Parent | $-13.63 Million |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Comprehensive Income/Loss | $-13.63 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Accounts Payable | $232,000 |
Equity Attributable To Parent | $9.71 Million |
Current Liabilities | $2.25 Million |
Noncurrent Liabilities | $0 |
Liabilities | $2.25 Million |
Fixed Assets | $20,000 |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Recent Headlines From The Web
Latest news, press releases, and media coverage about AMIX from trusted financial sources
Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2025 Financhle. All Rights Reserved.